Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
A conversation with William Ma, Global CIO of GROW Investment Group, hosted by Alvin Fan, CEO of OP Investment Management, filmed on 28 Nov 2023.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alvin Fan, CEO of OP Investment Management
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
How to Make Your Business Run Without You: Essential Tips for Small Business Owners | Ron Bernstein, Co-Founder, Prism Planning Partners, LLC.
00:10:00
Strategic Growth and Innovations Propel Cannabis Industry Success | Miguel Martin, CEO, Aurora Cannabis Inc.
00:10:00
Fund of Funds vs. Feeder Fund: Understanding Key Differences in Investment Structures | Chris Barsness, Founder, Securities Law Media
00:10:00
Sondrel (Holdings) PLC presents its investor update, while the CEO of Teleperformance cautions that AI lacks common sense in decision-making.
00:10:00
Backs entrepreneurs who are a lot like them|Greg Sands,Founder and Managing Director,Costanoa Ventures
00:10:00
Maximizing Returns with ETFs: MCS's Tactical Investment Strategy
00:10:00
Dundee Precious Metals: Transforming Assets and Leading in Sustainability
00:10:00
Orlando Bravo: Architect of Success at Thoma Bravo | Orlando Bravo, Founder, Thoma Bravo.
00:10:00
AnalytixInsight Inc. (TSX-V: ALY) (OTCQB: ATIXF) | Chaith Kondragunta, CEO, AnalytixInsight IncALY:CVE
00:10:00
Jonathan Pollock Discusses Crypto, China, and Global Markets at Bloomberg Invest Global Summit
00:10:00
TN Resources CEO Peter Mullens on Strategic Shift to Serbia and Future Development Plans
00:10:00
Discover the crown|Amy LaMeyer,Managing Partner,WXR Fund